featured
No Benefit of Continuing vs Stopping 5-Aminosalicylates in Patients With UC Escalated to Antimetabolite Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Alimentary Pharmacology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
No Benefit of Continuing vs Stopping 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Anti-Metabolite Therapy
Aliment. Pharmacol. Ther. 2020 Aug 01;52(3)481-491, S Singh, J Kim, W Zhu, PS Dulai, WJ Sandborn, V JairathFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.